The Latest

• July 15, 2020

  By Charleston Lim

  Shanghai Fosun Pharmaceutical Shares Surge After Beijing Approves Vaccine Trials

  The National Medical Products Administration (NMPA) has approved Fosun Pharmaceutical's clinical trial application for its Covid-19 mRNA vaccine candidate.

  

  The National Medical Products Administration (NMPA) has approved Fosun Pharmaceutical's clinical trial application for its Covid-19 mRNA vaccine candidate.